News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gemmus Pharma Retains Woodside Capital Partners As Advisor And Investment Bank


1/7/2014 10:11:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--Gemmus, a privately-held biotechnology company focused on the development of innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases, announced today that the company has entered into an agreement with Woodside Capital Partners, retaining them as the company’s advisor and investment bank.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES